Peer-reviewedCC BY-NCPulmonary circulation
β‐sitosterol Alleviates Pulmonary Arterial Hypertension in Rats With Involvement of the VEGF/PI3K/AKT Signaling Pathway
- 1Guangxi Clinical Research Center for Cardio‐cerebrovascular Diseases
- 2The First Affiliated Hospital of Guangxi Medical University
Related
- Macrostemonoside I alleviates metabolic dysfunction-associated steatotic liver disease in mice: potential involvement of SCAP/SREBP2 signaling in cholesterol metabolism.
- Geniposide alleviates CCl₄-induced liver fibrosis: Potential involvement of the PERK-CHOP signaling pathway.
- Effect of Activin Type II Receptor Signaling in Patients With HFpEF and Pulmonary Hypertension: A Critical Analysis of Biological Mechanisms and Clinical Trials
- Inhibiting MD2 activates AMPK-dependent PPARγ/NOX4 signaling to attenuate mitochondrial oxidative stress and relieve pulmonary hypertension
- Compensatory activation of PI3K/AKT signaling and apoptosis-associated protein expression in pulmonary hypertension-induced right ventricular dysfunction
BibTeX
@article{wu2026βsitosterol,
title = {{β‐sitosterol Alleviates Pulmonary Arterial Hypertension in Rats With Involvement of the VEGF/PI3K/AKT Signaling Pathway}},
author = {Xiaobing Wu and Chen Gong and Zhiyu Zeng},
journal = {Pulmonary circulation},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13660722},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - β‐sitosterol Alleviates Pulmonary Arterial Hypertension in Rats With Involvement of the VEGF/PI3K/AKT Signaling Pathway
AU - Xiaobing Wu
AU - Chen Gong
AU - Zhiyu Zeng
PY - 2026
DA - 2026/10/01
JO - Pulmonary circulation
UR - https://europepmc.org/article/PMC/PMC13660722
SN - 2045-8932
SN - 2045-8940
ER -